Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2361]
News [4942]
Articles [204]
Editorials [8]
Conferences [138]
elearning [14]
The role of physicians and researchers in the medical community
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
The role of physicians and researchers in the medical community ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
Achievements of the WIN Consortium
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Achievements of the WIN Consortium ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
Goal of the 2013 WIN Symposium
Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller
Goal of the 2013 WIN Symposium ( Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller )
23 Apr 2013
Myeloma UK
Eric Low - Chief Executive, Myeloma UK
Myeloma UK ( Eric Low - Chief Executive, Myeloma UK )
6 Apr 2013
Challenging paradigms in multiple myeloma
Prof Antonio Palumbo - University of Torino, Italy
Challenging paradigms in multiple myeloma ( Prof Antonio Palumbo - University of Torino, Italy )
6 Apr 2013
Whole genome sequencing reveals underlying genetics of multiple myeloma
Dr Jonathan Keats - The Translational Genomics Research Institute (TGen)...
Whole genome sequencing reveals underlying genetics of multiple myeloma ( Dr Jonathan Keats - The Translational Genomics Research Institute (TGen), Phoenix, USA )
4 Apr 2013
Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic...
Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA
Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia ( Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA )
13 Dec 2012
Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell...
Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA
Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell transplant ( Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA )
13 Dec 2012
Potential targets and complications of apoptosis and necrosis
Dr Doug Green – St Jude Children’s Research Hospital, Memphis, USA
Potential targets and complications of apoptosis and necrosis ( Dr Doug Green – St Jude Children’s Research Hospital, Memphis, USA )
7 Dec 2012
Personalised medicine in metastatic colorectal cancer
Dr Alberto Villanueva – Catalan Institute of Oncology – IDIBELL, Barcelona...
Personalised medicine in metastatic colorectal cancer ( Dr Alberto Villanueva – Catalan Institute of Oncology – IDIBELL, Barcelona, Spain )
7 Dec 2012
Prognostic signatures in colon cancer
Dr Ramon Salazar – Catalan Institut of Oncology, Barcelona, Spain
Prognostic signatures in colon cancer ( Dr Ramon Salazar – Catalan Institut of Oncology, Barcelona, Spain )
7 Dec 2012
Highlights from the 4th EUTROC meeting
Prof John Green – University of Liverpool, UK
Highlights from the 4th EUTROC meeting ( Prof John Green – University of Liverpool, UK )
15 Nov 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation